TWIL
ABBV icon

TrueNorth Wealth & Impact, LLC’s AbbVie ABBV Stock Holding History

TrueNorth Wealth & Impact, LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$514K Buy
+1,966
New +$504K 0.2% 79

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

TrueNorth Wealth & Impact, LLC's ABBV Position: Q3 2026 in Review

TrueNorth Wealth & Impact, LLC opened a new position in AbbVie (ABBV) in Q3 2026: 1,966 shares worth $514K. The stake represents 0.2% of the portfolio and ranks #79 among its holdings.

3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • TrueNorth Wealth & Impact, LLC held 1,966 shares of AbbVie worth $514K as of Q3 2026.
  • AbbVie was a new TrueNorth Wealth & Impact, LLC position in Q3 2026.
  • AbbVie made up 0.2% of TrueNorth Wealth & Impact, LLC's portfolio in Q3 2026, its #79 holding.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on TrueNorth Wealth & Impact, LLC's 13F filing for Q3 2026, filed 13 Nov 2026.